NLRP3 and graft versus host disease: The mechanism underlying the association of the higher-expression allele/genotype of the recipient NLRP3 with better OS in the patients who received transplants from CMV-negative donors remains unclear, largely because these interactions were not significantly associated with NRM, relapse, or GVHD, but were probably derived from effects on both NRM and relapse.